+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pfizer Inc. - logo

Pfizer is an American pharmaceutical corporation that develops and produces medicines and vaccines for a wide range of therapeutic areas, including immunology, oncology and cardiology. It is among the world’s largest pharmaceutical companies, with well known products like Lipitor, Lyrica and Viagra. The company was founded in 1849 and is headquartered in New York City, with its research headquarters in Groton, Connecticut. Pfizer employs approximately 90,000 workers worldwide.

Vaccines Market - Global Forecast 2026-2032 - Product Thumbnail Image

Vaccines Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
Adult Vaccines Market - Global Forecast 2026-2032 - Product Thumbnail Image

Adult Vaccines Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Meningococcal Vaccines Market - Global Forecast 2026-2032 - Product Thumbnail Image

Meningococcal Vaccines Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
From
Pneumococcal Vaccine Market - Global Forecast 2026-2032 - Product Thumbnail Image

Pneumococcal Vaccine Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 192 Pages
  • Global
From
Influenza Vaccine Market - Global Forecast 2026-2032 - Product Thumbnail Image

Influenza Vaccine Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
Therapeutic Vaccines Market - Global Forecast 2026-2032 - Product Thumbnail Image

Therapeutic Vaccines Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
Conjugate Vaccine Market - Global Forecast 2026-2032 - Product Thumbnail Image

Conjugate Vaccine Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 186 Pages
  • Global
From
From
Migraine Drugs - Global Strategic Business Report - Product Thumbnail Image

Migraine Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 193 Pages
  • Global
From
From
From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 382 Pages
  • Global
From
Anticholinergic Drugs - Global Strategic Business Report - Product Thumbnail Image

Anticholinergic Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 276 Pages
  • Global
From
Epilepsy Drugs - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 276 Pages
  • Global
From
Myasthenia Gravis Drugs - Global Strategic Business Report - Product Thumbnail Image

Myasthenia Gravis Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 182 Pages
  • Global
From
Insomnia Drugs - Global Strategic Business Report - Product Thumbnail Image

Insomnia Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 189 Pages
  • Global
From
Facial Palsy - Global Strategic Business Report - Product Thumbnail Image

Facial Palsy - Global Strategic Business Report

  • Report
  • April 2026
  • 367 Pages
  • Global
From
GLP-1 Receptor Agonist - Global Strategic Business Report - Product Thumbnail Image

GLP-1 Receptor Agonist - Global Strategic Business Report

  • Report
  • April 2026
  • 483 Pages
  • Global
From
Catecholamines - Global Strategic Business Report - Product Thumbnail Image

Catecholamines - Global Strategic Business Report

  • Report
  • April 2026
  • 372 Pages
  • Global
From
Loading Indicator